HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaobing Wang Selected Research

Xerophthalmia

2/2019Clinical features and potential relevant factors of renal involvement in primary Sjögren's syndrome.
1/2018Clinical features and risk factors of neurological involvement in Sjögren's syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaobing Wang Research Topics

Disease

102Neoplasms (Cancer)
08/2022 - 01/2006
27Breast Neoplasms (Breast Cancer)
08/2022 - 01/2007
14Leukemia
04/2016 - 04/2007
11Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 01/2014
10Glioma (Gliomas)
06/2021 - 07/2017
9Sarcoma 180
12/2015 - 12/2006
7Inflammation (Inflammations)
07/2022 - 01/2016
7Alzheimer Disease (Alzheimer's Disease)
12/2021 - 05/2015
7Infections
03/2021 - 11/2013
7Crohn Disease (Crohn's Disease)
01/2017 - 01/2013
6Necrosis
02/2022 - 06/2013
6Hepatocellular Carcinoma (Hepatoma)
12/2021 - 01/2008
6Neoplasm Metastasis (Metastasis)
06/2019 - 01/2015
6Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2017 - 01/2013
4Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 01/2017
4Burns
03/2021 - 01/2017
4Colitis
01/2017 - 01/2014
3COVID-19
07/2022 - 01/2021
3Hypertension (High Blood Pressure)
12/2021 - 07/2010
3Anemia
12/2021 - 09/2011
3Type 2 Diabetes Mellitus (MODY)
08/2021 - 10/2017
3Lung Neoplasms (Lung Cancer)
04/2021 - 07/2017
3Stomach Neoplasms (Stomach Cancer)
08/2020 - 03/2015
3Brain Neoplasms (Brain Tumor)
01/2020 - 01/2019
3Esophageal Neoplasms (Esophageal Cancer)
12/2018 - 01/2014
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2015 - 11/2013
3Leukemia L1210
07/2014 - 04/2011
3Lymphoma (Lymphomas)
05/2011 - 07/2006
2Parkinson Disease (Parkinson's Disease)
01/2022 - 11/2016
2Hypoxia (Hypoxemia)
10/2021 - 01/2021
2Pain (Aches)
05/2021 - 01/2015
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 10/2020
2Triple Negative Breast Neoplasms
01/2021 - 06/2015
2Wounds and Injuries (Trauma)
03/2020 - 01/2020
2Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2020 - 01/2020
2Non-alcoholic Fatty Liver Disease
01/2020 - 03/2016

Drug/Important Bio-Agent (IBA)

18protoporphyrin IXIBA
04/2016 - 12/2006
171-phenyl-3,3-dimethyltriazene (PDT)IBA
04/2021 - 09/2013
13Pharmaceutical PreparationsIBA
10/2021 - 01/2015
11sinoporphyrin sodiumIBA
08/2022 - 01/2014
11Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2014
11LigandsIBA
07/2021 - 07/2006
9Biological ProductsIBA
05/2021 - 02/2009
8Proteins (Proteins, Gene)FDA Link
07/2022 - 07/2008
8EnzymesIBA
02/2021 - 01/2007
7phytochlorinIBA
12/2016 - 11/2013
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 12/2008
6Liposomes (Liposome)IBA
06/2021 - 10/2017
6HematoporphyrinsIBA
02/2010 - 01/2008
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2022 - 03/2015
5Membrane Proteins (Integral Membrane Proteins)IBA
11/2019 - 07/2008
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 05/2014
4Messenger RNA (mRNA)IBA
07/2022 - 01/2012
4AntigensIBA
01/2022 - 01/2015
4Peptides (Polypeptides)IBA
10/2021 - 07/2006
4PorphyrinsIBA
05/2021 - 01/2018
4Interleukin-6 (Interleukin 6)IBA
03/2021 - 01/2017
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2021 - 03/2015
4Indicators and Reagents (Reagents)IBA
01/2019 - 02/2013
4Growth Differentiation Factor 15IBA
01/2018 - 08/2014
3Amyloid (Amyloid Fibrils)IBA
01/2022 - 01/2018
3Therapeutic UsesIBA
10/2021 - 07/2016
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
06/2021 - 11/2017
3Photosensitizing Agents (Photosensitizers)IBA
05/2021 - 03/2016
3Glucose (Dextrose)FDA LinkGeneric
05/2021 - 10/2017
3LipidsIBA
03/2021 - 03/2008
3AntioxidantsIBA
01/2021 - 01/2008
3CytokinesIBA
01/2021 - 01/2017
3Small Interfering RNA (siRNA)IBA
08/2020 - 06/2015
3asiaticosideIBA
01/2020 - 02/2018
3Doxorubicin (Adriamycin)FDA LinkGeneric
11/2019 - 11/2014
3Chloroform (Trichloromethane)IBA
01/2017 - 08/2012
3Antineoplastic Agents (Antineoplastics)IBA
11/2016 - 11/2013
3Eosine Yellowish-(YS) (Eosin)IBA
07/2016 - 01/2015
3Hematoxylin (Haematoxylon)IBA
07/2016 - 01/2015
3coumarinIBA
04/2016 - 07/2010
3Actins (F Actin)IBA
03/2016 - 03/2008
2ChemokinesIBA
07/2022 - 01/2014
2Aflatoxin B1 (Aflatoxin B)IBA
12/2021 - 01/2021
2Uric Acid (Urate)IBA
12/2021 - 01/2021
2Phosphotransferases (Kinase)IBA
12/2021 - 12/2008
2Transferrin (beta 2 Transferrin)IBA
06/2021 - 11/2017
2InterferonsIBA
01/2021 - 01/2021
216S Ribosomal RNAIBA
01/2021 - 02/2014
2interleukin-21 (interleukin 21)IBA
01/2021 - 05/2015
2Adenosine Triphosphate (ATP)IBA
01/2021 - 01/2019
2RNA (Ribonucleic Acid)IBA
01/2021 - 01/2020
2Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
01/2020 - 01/2016
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2020 - 01/2020

Therapy/Procedure

71Therapeutics
01/2022 - 07/2006
19Drug Therapy (Chemotherapy)
01/2022 - 12/2008
18Photochemotherapy (Photodynamic Therapy)
05/2021 - 09/2013
7Lasers (Laser)
04/2021 - 08/2014
7Precision Medicine
12/2020 - 01/2015
4Ultrasonic Therapy
09/2021 - 02/2009
4Aftercare (After-Treatment)
01/2020 - 11/2014
3Photothermal Therapy
06/2021 - 11/2017
3Microbubbles
11/2016 - 11/2014
2Immunotherapy
05/2021 - 01/2021
2Phototherapy (Light Therapy)
03/2021 - 01/2019